Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects
Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the safety, tolerability and pharmacokinetics of multiple
oral 200-mg doses of Pf-05175157 administered twice daily for 14 days in healthy overweight
and obese subjects.